Joann Lindenfeld, MD
Enriched profileProfessor of Medicine, Division of Cardiovascular Medicine · Vanderbilt University Medical Center
Joann Lindenfeld is Professor of Medicine, Division of Cardiovascular Medicine at Vanderbilt University Medical Center. OpenAlex indexes 650 publications with 28,897 citations (h-index 75); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Advanced Heart Failure and Transplant Cardiology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Joann Lindenfeld, MD, is Professor of Medicine, Division of Cardiovascular Medicine at Vanderbilt University Medical Center. The public record shows 650 publications with 28,897 citations (h-index 75), centered on Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Mechanical Circulatory Support Devices. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 12 companies, 1 NIH-funded awards (2018–2025).
- Most recent indexed publication: 2026 · Circulation. Heart failure
- Top research focus: Heart Failure Treatment and Management
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 275.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR
Sponsor: Abbott Medical Devices
Industry payments
Updated 27 Aug 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20257 payments$12,871openpaymentsdata.cms.gov ↗
- CVRx, Inc.Program year20253 payments
- Edwards Lifesciences CorporationProgram year20254 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.3%Beta blocker27.7%Metoprolol Succinate77%Carvedilol23%Part D<11 patientsAldosterone antagonist (MRA)14.9%Spironolactone100%Part D≥11 patientsMetabolism & gastrointestinal
13.8%SGLT2 inhibitor13.8%Jardiance100%Part D<11 patientsBlood & clotting
5.9%Factor Xa inhibitor5.9%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2018–2025 per NIH RePORTER. The latest:
- Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
Volumetrix, Llc
FY2025$1,000,000R44HL140669 - Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
Volumetrix, Llc
FY2025$175,700R44HL140669 - Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
Volumetrix, Llc
FY2024$1,000,000R44HL140669
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Prediction of Heart Failure Hospitalization or Death After TAVR.
Circulation. Cardiovascular interventions
Article2026 - Impact of Natriuretic Peptide and Prior Hospitalization in Patients With Severe Mitral Regurgitation: COAPT Trial.
Circulation. Cardiovascular interventions
Clinical Trial2025 - Association of Novel Ventricular Assist Device Self-report Measures With Overall Health-Related Quality of Life.
The Journal of cardiovascular nursing
Article2025 - Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and All-Cause Mortality in Patients With Chronic Heart Failure.
Circulation. Heart failure
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 02Transcatheter Mitral-Valve Repair in Patients with Heart Failure2,926 citations2018
- 03State of the Science967 citations2009
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/joann-lindenfeld-059638104
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/joann-lindenfeld-923859aa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/JoAnn-Lindenfeld-2048466805
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/vanderbilt-university-medical-center_joann-lindenfeld-md-professor-of-medicine-activity-6854732582232313856-uXMN
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
news.vumc.org/2021/10/07/lindenfeld-honored-by-heart-failure-society-of-america
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org ↗ - Other
news.vumc.org/tag/joann-lindenfeld
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wag.app.vanderbilt.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org ↗
- Steering committee member for major heart failure device trials including COAPT
GUIDE-HF, BEAT-HF, and RELIEVE-HF
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →media.mycme.com ↗
Awards & honors
honors on the public record- Pioneer Award
Heart Failure Society of America (HFSA), 2021, honoring innovative/pioneering contributions to the field of heart failure
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardionerds.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center
Brian Rini, MD
Vanderbilt University Medical Center
William Schaffner, MD
Vanderbilt University Medical Center
Jordan Berlin, MD
Vanderbilt University Medical Center